UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Abiomed, Inc. of Class Action Lawsuit and the Deadline of January 15, 2013 to Seek a Lead Plaintiff Position

Tue Jan 8, 2013 5:49pm EST

* Reuters is not responsible for the content in this press release.

NEW YORK, NY, Jan 08 (Marketwire) -- 
Levi & Korsinsky announces that a class action lawsuit has been commenced
in the United States District Court for the District of Massachusetts on
behalf of investors who purchased Abiomed, Inc. ("Abiomed" or the
"Company") (NYSE: ABMD) stock between August 5, 2011 and October 31, 2012.

    For more information, click here: http://zlk.9nl.com/abiomed-abmd. 

    The complaint alleges that, throughout the Class Period, Abiomed made
materially misleading statements regarding the Company's financial
strength and prospects. In particular, it is alleged that positive
statements concerning the Company were misleading because the United
States Food and Drug Administration ("FDA") repeatedly warned Abiomed
that its promotional materials contained inappropriate claims regarding
its Impella 2.5 catheter and suggested improper off-label uses. Abiomed
repeatedly assured investors that they had addressed the FDA's concerns
and that the matter was resolved. 

    On November 1, 2012, Abiomed disclosed that the Department of Justice had
initiated an investigation "focused on the Company's marketing and
labeling of the Impella 2.5." On this news, shares of Abiomed's stock
fell from $19.82 per share on October 31, 2012 to close at $13.61 on
November 1, 2012. 

    If you suffered a loss in Abiomed you have until January 15, 2013 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead plaintiff.
To obtain additional information, contact Joseph E. Levi, Esq. either via
email at jlevi@zlk.com or by telephone at (877) 363-5972, or visit
http://zlk.9nl.com/abiomed-abmd.

    Levi & Korsinsky is a national firm with offices in New York and
Washington D.C. The firm has extensive expertise in prosecuting
securities litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. Attorney
advertising. Prior results do not guarantee similar outcomes.

    

CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 

Copyright 2013, Marketwire, All rights reserved.

-0-